Clinical Study on Transplantation of Autologous Peripheral Blood Stem Cells for the Treatment of Old Patients with Lower Limb Chronic Ischemia

钱爱民,李晓强,段鹏飞,桑宏飞,朱礼炜,戎建杰
DOI: https://doi.org/10.3969/j.issn.1674-7887.2007.02.011
2007-01-01
Abstract:Objective:To evaluate the clinical efficacy of mobilized autologous peripheral blood stem cells(PBSC) transplantation in old patients with lower limb chronic ischemia.Methods:18 old patients(20 legs) with lower limb chronic ischemia were treated by autologous transplantation of mobilized PBSC from Oct.2004 to Mar.2006.They were 12 men and 6 women.10 patients affected by lower limb arteriosclerosis obliterans(ASO) ,8 patients by diabetic feet.The mean ages was 69 years(from 62 to 82) .They all received the same dose of granulocyte colony-stimulating factor(G-CSF) 300μg/d by hypodermic injection to mobilize stem cells for 4~6 days.PBSC were separated by a blood-cells separator into suspending liquid when the count number of white blood cell in peripheral blood exceed 30?a109/L.Part of the PBSC suspension without treatment was injected into the skeletal muscles of the ischemic leg and the remainder was infused into ischemia-related artery of the same leg through balloon center lumen.Results:After the stem cell transplantation,the general rate of relieving pain and local cool-feeling in leg was 100%,the walking distance of 14 patients with intermittent claudication was obviously longer.One month after the transplantation,angiography showed a noticeable increase in visible collateral vessels in 6 patients with 7 limbs who had DSA angiography follow-up.No related severe complications or adverse effects were observed in this group.Conclusion:Transplantation of mobilized autologous PBSC might be simple,safe and effective for the treatment of old patients with lower limb chronic ischemia,but its long term effect need follow up more longer time and even in more patients.
What problem does this paper attempt to address?